Opportunity Information: Apply for PAR 09 077

  • The National Institutes of Health in the food and nutrition health sector is offering a public funding opportunity titled "Pilot and Feasibility Clinical Research Grants in Kidney or Urologic Diseases (R21)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research.
  • This funding opportunity was created on Jan 14, 2009 and posted on Jan 14, 2009.
  • Applicants must submit their applications by Jan 7, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $200,000.00 in funding.
  • Eligible applicants include: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments Others (see text field entitled Additional Information on Eligibility for clarification) Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) County governments Small businesses Independent school districts Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments For profit organizations other than small businesses Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Special district governments.
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
Apply for PAR 09 077

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Pilot and Feasibility Clinical Research Grants in Kidney or Urologic Diseases (R21) funding opportunity (PAR-09-077) is a National Institutes of Health program issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to support early-stage, small-scale clinical and translational studies focused on kidney and urologic diseases. The central aim is to help researchers test promising ideas quickly and efficiently through pilot or feasibility work that answers important clinical or translational questions and has the potential to lead to meaningful improvements in patient care or public health. The program explicitly welcomes projects that may be exploratory in nature but are still grounded in clinical relevance, such as studies that evaluate new approaches to diagnosis, prevention, or treatment, or that clarify disease patterns and outcomes in patient populations.

This opportunity uses the NIH Exploratory/Developmental Research Grant mechanism (R21), which is designed for projects that are not yet ready for a large, definitive clinical study but have strong rationale and clear potential. In practice, that means applicants are expected to propose focused research that can generate key preliminary data, demonstrate feasibility of recruitment and procedures, refine an intervention or diagnostic strategy, validate outcome measures, or identify signals that justify a subsequent larger-scale investigation. The announcement notes that some funded projects are anticipated to evolve into full-scale clinical efforts, including larger epidemiological studies, diagnostic strategy studies, or randomized clinical trials aimed at diagnosing, preventing, or treating kidney or urologic diseases.

The types of studies encouraged include clinical and translational research broadly, and it specifically mentions epidemiological studies and clinical trials as examples of allowable research directions, as long as they remain within a pilot or feasibility scope consistent with the R21 mechanism. The emphasis is on studies that can have high clinical and public health impact, meaning reviewers will likely prioritize proposals that address significant disease burdens, unmet clinical needs, or clear gaps in current practice, and that can plausibly inform the next steps toward larger trials or implementation-focused research.

From an administrative and funding perspective, awards under this FOA are contingent on the availability of funds and the receipt of a sufficient number of meritorious applications, which is standard NIH language indicating that funding decisions depend on both budget and application quality. The listed award ceiling is $200,000. The program is categorized as a discretionary grant opportunity, and it is associated with CFDA number 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research). There is no cost sharing or matching requirement, so applicants are not required to contribute non-federal funds as a condition of the award.

Eligibility is broad and includes many types of organizations. Eligible applicants include public and private institutions of higher education, nonprofit organizations with or without 501(c)(3) status, for-profit entities (including small businesses and other for-profits), and a wide range of government bodies such as state governments, county governments, city or township governments, special district governments, independent school districts, and public housing authorities/Indian housing authorities. The FOA also allows participation from tribal governments and tribal organizations, including federally recognized tribal governments as well as other tribal entities. In addition, it explicitly includes organizations such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, faith-based or community-based organizations, regional organizations, and U.S. territories or possessions. Notably, non-U.S. entities (foreign organizations) are also listed as eligible, which can be important for international clinical or epidemiological work relevant to kidney or urologic disease.

Key dates provided indicate the opportunity was posted on January 14, 2009, with an original and current closing date of January 7, 2012, and an archive date of February 7, 2012. That means this particular announcement is no longer active as written, but it remains useful as a description of the kind of pilot and feasibility kidney/urologic clinical research NIDDK has sought to stimulate under the R21 mechanism. For applicants seeking current opportunities, the archived FOA can serve as a template for understanding NIH expectations, while a live NIH listing would be needed for up-to-date submission dates and current policy requirements.

For additional details, the FOA points to the NIH Grants Guide webpage associated with PAR-09-077. The contact information provided is primarily technical support through the NIH Office of Extramural Research (OER) webmaster for access or linking issues, rather than a scientific or grants management program contact.

Frequently Asked Questions (FAQs)

What is the name of this grant opportunity?

The opportunity is titled Pilot and Feasibility Clinical Research Grants in Kidney or Urologic Diseases (R21), Funding Opportunity Announcement (FOA) PAR-09-077.

Which agency and institute offer this opportunity?

This is a National Institutes of Health (NIH) program issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

What is the main purpose of this FOA?

The central aim is to support early-stage, small-scale clinical and translational studies in kidney and urologic diseases. It is intended to help researchers test promising ideas quickly through pilot or feasibility work that answers important clinical or translational questions and could lead to meaningful improvements in patient care or public health.

What grant mechanism does this use?

This FOA uses the NIH Exploratory/Developmental Research Grant (R21) mechanism.

What does it mean that this is an R21 (exploratory/developmental) award?

It means the proposed project is expected to be focused and appropriate for a stage where it is not yet ready for a large, definitive clinical study, but it has a strong rationale and clear potential. Typical R21-aligned goals include generating key preliminary data, showing feasibility, refining approaches, and identifying signals that justify a larger follow-on study.

What research areas are in scope?

Projects must focus on kidney or urologic diseases and be grounded in clinical relevance. The FOA supports clinical and translational research, including exploratory projects that still address meaningful clinical or translational questions.

What types of studies are encouraged?

The FOA encourages pilot or feasibility-scale studies such as those evaluating new approaches to diagnosis, prevention, or treatment, and studies that clarify disease patterns and outcomes in patient populations. It also mentions epidemiological studies and clinical trials as allowable examples, as long as they remain within a pilot/feasibility scope consistent with an R21.

Are clinical trials allowed under this FOA?

Yes. The FOA specifically mentions clinical trials as an allowable direction, provided the trial is designed as a pilot or feasibility effort appropriate for the R21 mechanism.

Are epidemiological studies allowed under this FOA?

Yes. The FOA explicitly mentions epidemiological studies as an example of allowable research, as long as the work remains within a pilot or feasibility scope.

What kinds of outcomes should an R21 project aim to produce?

Examples described in the FOA include generating preliminary data, demonstrating feasibility of recruitment and procedures, refining an intervention or diagnostic strategy, validating outcome measures, and identifying signals that justify a subsequent larger-scale investigation.

Does NIDDK expect projects funded under this FOA to lead to larger studies?

The FOA notes that some funded projects are anticipated to evolve into fuller-scale clinical efforts, including larger epidemiological studies, diagnostic strategy studies, or randomized clinical trials aimed at diagnosing, preventing, or treating kidney or urologic diseases.

What is the maximum award amount listed?

The listed award ceiling is $200,000.

Is cost sharing or matching required?

No. The FOA states there is no cost sharing or matching requirement.

Is funding guaranteed if an application is submitted?

No. Awards are contingent on availability of funds and on receiving a sufficient number of meritorious applications, meaning both budget and application quality affect funding decisions.

What is the CFDA number associated with this opportunity?

The opportunity is associated with CFDA 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research).

What type of grant opportunity is this categorized as?

It is categorized as a discretionary grant opportunity.

Who is eligible to apply?

Eligibility is broad. Eligible applicants include public and private institutions of higher education; nonprofit organizations with or without 501(c)(3) status; for-profit entities (including small businesses); and many government entities (state, county, city/township, special district governments, independent school districts, and public housing authorities/Indian housing authorities).

Are tribal governments and tribal organizations eligible?

Yes. The FOA allows participation by federally recognized tribal governments as well as other tribal entities and tribal organizations.

Are specific institution types like HBCUs or Hispanic-serving institutions eligible?

Yes. The FOA explicitly includes organizations such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and faith-based or community-based organizations, among others.

Are U.S. territories or possessions eligible?

Yes. The FOA explicitly includes U.S. territories or possessions.

Are non-U.S. (foreign) organizations eligible to apply?

Yes. The FOA lists non-U.S. entities (foreign organizations) as eligible applicants.

When was this FOA posted, and what were the closing and archive dates?

The FOA was posted on January 14, 2009. The original and current closing date listed is January 7, 2012, and the archive date is February 7, 2012.

Is this funding opportunity still active?

No. Based on the closing date (January 7, 2012) and archive date (February 7, 2012), this particular announcement is no longer active as written.

How should someone use this FOA today if it is archived?

The FOA can still be useful as a template for understanding the kind of pilot and feasibility kidney/urologic clinical research NIDDK has supported under the R21 mechanism, but applicants would need a current NIH listing for up-to-date submission dates and current policy requirements.

Where does the FOA direct applicants for additional details?

The FOA points to the NIH Grants Guide webpage associated with PAR-09-077.

What contact information is provided in the FOA?

The contact information provided is primarily for technical support through the NIH Office of Extramural Research (OER) webmaster, intended for access or linking issues rather than scientific or grants management questions.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Food and Nutrition Health

Next opportunity: Child Care Research Scholars

Previous opportunity: BLM ID Inland Empire Tree Improvement Coop

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 09 077

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 09 077) also looked into and applied for these:

Funding Opportunity
Small Business Innovation Research Competing Renewal Awards for Biomedical and Behavior Research Tools (SBIR R44) Apply for PA 08 115

Funding Number: PA 08 115
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Diabetes Research Centers (P30, P60) Apply for RFA DK 08 008

Funding Number: RFA DK 08 008
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Integrated Research, Education, and Extension Competitive Grant Program National Integrated Food Safety Initiative Apply for USDA CSREES ICGP 002098

Funding Number: USDA CSREES ICGP 002098
Agency: CSREES
Category: Food and Nutrition Health
Funding Amount: $2,000,000
Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21) Apply for PA 09 131

Funding Number: PA 09 131
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $200,000
Pilot and Feasibility Clinical Research Grants in Diabetes, Endocrine and Metabolic Diseases (R21) Apply for PA 09 133

Funding Number: PA 09 133
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $200,000
Silvio O. Conte Digestive Diseases Research Core Centers (P30) Apply for RFA DK 09 005

Funding Number: RFA DK 09 005
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $750,000
Renal Function and Chronic Kidney Disease in Aging (R01) Apply for PA 09 165

Funding Number: PA 09 165
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Nutrition Obesity Research Centers (P30) Apply for RFA DK 09 006

Funding Number: RFA DK 09 006
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $750,000
Non Invasive Methods for Diagnosis and Progression of Diabetes, Kidney, Urological, Hematological and Digestive Diseases and Hypertensive Disorders (R01) Apply for PA 09 181

Funding Number: PA 09 181
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Ancillary Studies of Acute Kidney Injury, Chronic Kidney Disease, and End Stage Renal Disease Accessing Information from Clinical Trials, Epidemiological Studies, and Databases (R01) Apply for PA 09 196

Funding Number: PA 09 196
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Advances in Polycystic Kidney Disease (R01) Apply for PA 09 202

Funding Number: PA 09 202
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
NIDDK Small Grants for Clinical Scientists to Promote Diversity in Health Related Research (R03) Apply for PAR 09 223

Funding Number: PAR 09 223
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $125,000
Public Private Alliances Related to Nutrition in Peru Apply for M OAA GRO EGAS 09 232 HPERU

Funding Number: M OAA GRO EGAS 09 232 HPERU
Agency: Agency for International Development
Category: Food and Nutrition Health
Funding Amount: $1,500,000
Calcium Oxalate Stone Diseases (R01) Apply for PA 09 213

Funding Number: PA 09 213
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Consortium of Food Allergy Research (CoFAR) and CoFAR Statistical and Clinical Coordinating Center (CoFAR SACCC) (U19 and U01) Apply for RFA AI 09 039

Funding Number: RFA AI 09 039
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Small Grant Program for NIDDK K01/K08/K23 Recipients (R03) Apply for PAR 09 230

Funding Number: PAR 09 230
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $50,000
Cystic Fibrosis Research and Translation Core Centers (P30) Apply for RFA DK 09 009

Funding Number: RFA DK 09 009
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $750,000
Ancillary Studies to Major Ongoing Clinical Research Studies to Advance Areas of Scientific Interest within the Mission of the NIDDK (R01) Apply for PAR 09 247

Funding Number: PAR 09 247
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Pilot Studies for Studying the Mechanisms of Improvement in Type 2 Diabetes and Cardiovascular Risk Factors or in Cardiovascular, Lung, or Sleep Diseases after Bariatric Surgery (R01) Apply for RFA DK 09 012

Funding Number: RFA DK 09 012
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $400,000
Beta Cell Biology Consortium (U01) Apply for RFA DK 09 011

Funding Number: RFA DK 09 011
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 09 077", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.